NeuroPace Inc (NPCE): Capital Expenditures
$332.0K
Year ended 2025-12-31
$369.0K
Trailing 12 months to 2026-06-30
-18.0%
3-year compound annual growth
+39.9%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $332.0K | +8.5% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $306.0K | +76.9% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | $173.0K | -71.3% | 2025-03-04, From 2023-01-01 |
| 2022-12-31 | $603.0K | +57.0% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | $384.0K | +519.4% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | $62.0K | n/a | 2022-03-10, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| NeuroPace Inc (NPCE) | 2025-12-31 | $332.0K | +8.5% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $5.30M | +56.0% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $34.89M | +52.1% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $452.0K | -68.8% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $6.83M | -11.7% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $4.20M | +10.5% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $1.55M | +176.7% |
| Iradimed Corp (IRMD) | 2025-12-31 | $7.76M | -3.0% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $448.0K | -54.7% |
Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗